“There are several ways to build a massive business here,” Meta CEO Mark Zuckerberg told investors Wednesday in an attempt to calm investors over the company’s AI push, which he said could take years to pay off.| Forbes
The fund that was legally owned by Altman instead of OpenAI or its affiliates, has invested in an array of AI-powered companies in fields like healthcare, education and law.| Forbes
Musk, who founded OpenAI as a nonprofit with Altman and has criticized him for abandoning this model to seek profits, also feuded with writer Stephen King over the name of his social media platform, X.| Forbes
The Dutch data protection watchdog said Clearview had amassed an illegal and “highly intrusive” database of 30 billion facial images to provide facial recognition services to law enforcement agencies.| Forbes
OpenAI CEO Sam Altman and Google DeepMind CEO Demis Hassabis were among the tech leaders warning that AI could be as dangerous as pandemics and nuclear weapons.| Forbes
The WHO declared mpox a public health emergency of international concern in August amid an escalating outbreak of a worrying new variant in central Africa| Forbes
Bavarian Nordic produces one of the only vaccines for mpox and its shots are the only ones licensed for the disease in the U.S. and European Union.| Forbes
Unlike major competitors including Google’s Gemini and OpenAI’s ChatGPT, Meta’s Llama 3 model is open source and the AI assistant it powers has previously been locked inside the company’s app ecosystem, which includes Facebook and Instagram.| Forbes
Drugmaker Eli Lilly is hoping tirzepatide, sold as Mounjaro and Zepbound for diabetes and weight loss, will become the first drug approved to treat sleep apnea, which it says affects some 80 million Americans, many of whom go undiagnosed and untreated.| Forbes
Emerging research indicates drugs like Ozempic, Wegovy, Mounjaro and Zepbound could be useful in treating a variety of health conditions ranging from Parkinson’s and addiction to anxiety and fatty liver disease.| Forbes
Booming demand for weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound has vastly outpaced Novo Nordisk and Eli Lilly’s ability to produce the medication and supplies of smaller doses have been limited for months.| Forbes
mRNA specialist CureVac, which struggled to compete with the likes of Pfizer, Moderna and BioNTech, said it will focus on developing mRNA cancer vaccines and will cut 30% of its staff.| Forbes
OpenAI’s “next frontier model” is expected to replace the GPT-4 model powering ChatGPT.| Forbes
Experts told Forbes Johansson could have a strong case against OpenAI but warned technological advances have put other celebrities — and the public — at greater risk of imitation.| Forbes
In an interview with the Financial Times, Meta’s AI chief Yann LeCun said a “world modeling” approach could reach human levels of intelligence, but cautioned this was still around a decade away.| Forbes
OpenAI has acknowledged Sky, one of five voices for its ChatGPT voice assistant, sounds like Scarlett Johansson but said it belongs to a different voice actress and is “not an imitation.”| Forbes
OpenAI is reportedly announcing the AI-powered search engine on Monday, a day before Google is expected to give updates on its Gemini AI system at its annual developer conference.| Forbes
A senior State Department official urged Moscow and Beijing to follow the lead of Washington, London and Paris in vowing to keep nuclear weapons away from artificial intelligence and in human hands.| Forbes
Privacy activists have accused OpenAI of refusing to correct false and misleading information generated by ChatGPT in a well known issue of AI “hallucination.”| Forbes
Musk claimed OpenAI and Altman elected to use the company’s technology “to maximize profits” for Microsoft rather than for the benefit of humanity, adding that its entire line of development “is now veiled in secrecy.”| Forbes
